Press Releases

SAN MATEO, Calif., Aug. 5, 2019 /PRNewswire/ -- 3-V Biosciences, a clinical-stage biotechnology company, announced today that it has changed its name to Sagimet Biosciences and closed a second tranche of its Series E financing, which now totals $25 million.

WASHINGTON, Aug. 5, 2019 /PRNewswire/ -- Special Olympics has announced Alicia Bazzano, MD, PhD, MPH, as Chief Health Officer.  Dr. Bazzano is a pediatrician and public health executive who has dedicated her career to improving the health of people with intellectual disabilities (ID).

LEXINGTON, Mass., Aug. 5, 2019 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM) today reports its second quarter results.

JERUSALEM, Aug. 5, 2019 /PRNewswire/ -- RenalSense announced that it has obtained CE Mark approval for its Clarity RMS™ system for real-time monitoring of urine flow in the critical care and peri-operative setting. The CE Mark approval allows RenalSense to commercialize its technology in the European Union (EU), where Fresenius Medical Care (Bad Homburg) is i

INDIANAPOLIS, Aug. 5, 2019 /PRNewswire/ -- LifeOmic, the creator of LIFE mobile apps and the cloud platform in use at major medical and cancer centers, today announced its new precis

Presentation Scheduled for 11:30 am Eastern Time on August 8th NASDAQ, TSX: NVCN VANCOUVER, Aug. 5, 2019 /PRNewswire/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitr

PHILADELPHIA, Aug. 5, 2019 /PRNewswire/ -- The number of people struggling with opioid addiction in Pennsylvania has long been higher than the national average. In fact, the state ranks third for drug overdose deaths, according to the CDC.There simply aren't enough treatment beds in the area to provide those with drug or alco

DENVER, Aug. 5, 2019 /PRNewswire/ -- BLOCK21 Fitness, a new workout class program centered around cardio hip-hop fitness, opened its new studio today at 930 N.

NEW YORK, Aug. 5, 2019 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease (AD), today provided an update on clinical and corporate developments, including its ongoing confirmatory Phase 2 study of Bryostatin-1 in moderate to severe AD, a

BEDFORD, Mass., Aug. 5, 2019 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced the unveiling of their latest innovation, the GEM Premier ChemSTAT in vitro diagnostic (IVD) analyzer with Intelligent Quality Management (iQM) at the American Association for Clinical Chemistry (AACC) Annual Meeting in